Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In the SURMOUNT-2 trial (patients with type 2 diabetes and obesity), the average weight loss was 14.7%
My provider made me very comfortable and was very helpful
The original weight management approval was based on the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program, which enrolled over 4,500 participants without diabetes
Muscle loss reduces metabolism, balance, mobility, and bone protection
Refined grains such as white bread, flour tortillas, and sandwich rolls are the single most disruptive food category for blood sugar stability
First, more Medicaid enrollees are being prescribed GLP-1s for obesity
US$ 29.52
US$ 24.56
US$ 24.37
US$ 22.22
US$ 26.16
US$ 20.66
US$ 21.87
US$ 27.11
